Profile
Full Name
Chemomab Therapeutics Ltd.Ticker Symbol
CMMBExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
IsraelIPO
February 12, 2019Indexes
Not includedWebsite
http://www.chemomab.comEmployees
20Key Details
Price
$1.18(+10.68%)
Market cap
$22.27M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$0.78(+62.14% YoY)
PE ratio
-
Next earnings date
May 9, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Chemomab Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Feb 20, 25 Maxim Group
BuyNov 15, 24 Oppenheimer
OutperformMay 13, 24 Maxim Group
BuyMay 6, 24 Oppenheimer
OutperformMar 8, 24 Oppenheimer
PerformOct 6, 23 Roth MKM
BuyJun 7, 23 Oppenheimer
PerformApr 18, 23 Oppenheimer
OutperformMar 10, 22 Oppenheimer
OutperformDec 7, 21 Aegis Capital
BuyInstitutional Ownership
- What is the ticker symbol for Chemomab Therapeutics?
- Does Chemomab Therapeutics pay dividends?
- What sector is Chemomab Therapeutics in?
- What industry is Chemomab Therapeutics in?
- What country is Chemomab Therapeutics based in?
- When did Chemomab Therapeutics go public?
- Is Chemomab Therapeutics in the S&P 500?
- Is Chemomab Therapeutics in the NASDAQ 100?
- Is Chemomab Therapeutics in the Dow Jones?
- When was Chemomab Therapeutics's last earnings report?
- When does Chemomab Therapeutics report earnings?
- Should I buy Chemomab Therapeutics stock now?
What is the ticker symbol for Chemomab Therapeutics?
The ticker symbol for Chemomab Therapeutics is NASDAQ:CMMB
Does Chemomab Therapeutics pay dividends?
No, Chemomab Therapeutics does not pay dividends
What sector is Chemomab Therapeutics in?
Chemomab Therapeutics is in the Healthcare sector
What industry is Chemomab Therapeutics in?
Chemomab Therapeutics is in the Biotechnology industry
What country is Chemomab Therapeutics based in?
Chemomab Therapeutics is headquartered in Israel
When did Chemomab Therapeutics go public?
Chemomab Therapeutics's initial public offering (IPO) was on February 12, 2019
Is Chemomab Therapeutics in the S&P 500?
No, Chemomab Therapeutics is not included in the S&P 500 index
Is Chemomab Therapeutics in the NASDAQ 100?
No, Chemomab Therapeutics is not included in the NASDAQ 100 index
Is Chemomab Therapeutics in the Dow Jones?
No, Chemomab Therapeutics is not included in the Dow Jones index
When was Chemomab Therapeutics's last earnings report?
Chemomab Therapeutics's most recent earnings report was on Mar 3, 2025
When does Chemomab Therapeutics report earnings?
The next expected earnings date for Chemomab Therapeutics is May 9, 2025
Should I buy Chemomab Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions